NCT03801759View on ClinicalTrials.gov

Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Drug Interaction Potentiation
Interventions
DRUG

Vadadustat

Oral dose 600 mg

DRUG

Furosemide

Oral Furosemide

DRUG

Adefovir

Oral Adefovir

DRUG

Digoxin

Oral Digoxin

Trial Locations (1)

G1P 0A2

inVentiv Health Clinique Inc., Québec

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY